IRIS - Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi dell’Insubria.

IRInSubria - Institutional Repository Insubria
IRInSubria raccoglie, conserva, documenta e dissemina le informazioni sulla produzione scientifica dell'Università degli Studi dell’Insubria anche ai fini della valutazione della ricerca.

SPANEVELLO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.837
EU - Europa 9.721
AS - Asia 5.788
SA - Sud America 909
AF - Africa 87
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 12
Totale 35.399
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.677
IT - Italia 4.867
SG - Singapore 1.949
UA - Ucraina 1.552
CN - Cina 1.244
HK - Hong Kong 828
BR - Brasile 778
VN - Vietnam 737
TR - Turchia 680
SE - Svezia 645
IE - Irlanda 549
GB - Regno Unito 547
DE - Germania 421
FI - Finlandia 403
RU - Federazione Russa 295
NL - Olanda 97
CA - Canada 85
FR - Francia 84
IN - India 78
AT - Austria 72
MX - Messico 60
AR - Argentina 53
JP - Giappone 48
BD - Bangladesh 46
PL - Polonia 36
AU - Australia 32
BE - Belgio 26
ZA - Sudafrica 23
CZ - Repubblica Ceca 21
EC - Ecuador 21
ES - Italia 20
ID - Indonesia 20
KR - Corea 20
MA - Marocco 19
CH - Svizzera 16
PK - Pakistan 15
IQ - Iraq 14
SA - Arabia Saudita 14
NZ - Nuova Zelanda 12
PE - Perù 12
TW - Taiwan 12
CL - Cile 11
CO - Colombia 11
EU - Europa 11
MY - Malesia 11
UZ - Uzbekistan 10
DZ - Algeria 9
LT - Lituania 9
RO - Romania 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
KZ - Kazakistan 8
EG - Egitto 7
IR - Iran 7
AL - Albania 6
GR - Grecia 6
JO - Giordania 6
NO - Norvegia 6
BO - Bolivia 5
DK - Danimarca 5
KE - Kenya 5
NG - Nigeria 5
PY - Paraguay 5
TH - Thailandia 5
TN - Tunisia 5
BG - Bulgaria 4
HU - Ungheria 4
LK - Sri Lanka 4
MD - Moldavia 4
OM - Oman 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
IL - Israele 3
MM - Myanmar 3
PA - Panama 3
SN - Senegal 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
GD - Grenada 2
GE - Georgia 2
GN - Guinea 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
LU - Lussemburgo 2
LY - Libia 2
SK - Slovacchia (Repubblica Slovacca) 2
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GF - Guiana Francese 1
GH - Ghana 1
GT - Guatemala 1
JM - Giamaica 1
KG - Kirghizistan 1
Totale 35.388
Salva come PNG Salva come JPEG
Città #
Milan 3.396
Fairfield 2.338
Woodbridge 1.831
Ashburn 1.427
Jacksonville 1.257
Houston 1.211
Ann Arbor 1.207
Chandler 1.100
Singapore 1.037
Wilmington 928
Seattle 926
Hong Kong 821
Cambridge 788
Dallas 544
Princeton 532
Dublin 531
Shenzhen 437
Dearborn 410
Boardman 380
Izmir 372
Nyköping 314
Dong Ket 285
Rome 271
Beijing 207
Chicago 201
The Dalles 181
New York 173
San Diego 168
London 150
Como 126
San Mateo 120
Los Angeles 119
Ogden 104
São Paulo 86
Hefei 75
Munich 70
Santa Clara 68
Helsinki 66
Washington 65
Ho Chi Minh City 58
Falls Church 57
Kocaeli 49
Council Bluffs 45
Nanjing 44
Tokyo 41
Hanoi 40
Vienna 40
Kunming 39
Nuremberg 39
Salt Lake City 37
San Francisco 37
Norwalk 36
Mexico City 34
Toronto 34
Rio de Janeiro 32
San Genesio Ed Uniti 32
Amsterdam 31
Phoenix 31
Verona 29
Warsaw 29
Brooklyn 27
Guangzhou 27
Atlanta 26
Chennai 26
Columbus 26
Montreal 25
Brussels 24
Düsseldorf 23
Jinan 23
Redmond 23
Redwood City 22
Tampa 22
Shanghai 21
Buffalo 20
Belo Horizonte 19
Magnago 18
Kilburn 17
Philadelphia 17
Stockholm 17
Brno 16
Dhaka 16
Nanchang 16
Shenyang 16
Orem 15
Pavia 15
Indiana 14
Manchester 14
Turku 14
Boston 13
Chiswick 13
New Bedfont 13
Zhengzhou 13
Ankara 12
Chengdu 12
Fayetteville 12
Frankfurt am Main 12
Johannesburg 12
Porto Alegre 12
Prescot 12
Varese 12
Totale 25.843
Salva come PNG Salva come JPEG
Nome #
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis 573
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases 304
The effects of a cognitive behavioural intervention in asthmatic patients. 253
Airway inflammation in patients affected by obstructive sleep apnea 250
Classifying new anti-tuberculosis drugs: rationale and future perspectives 225
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery. 220
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study 216
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis 209
A European Respiratory Society technical standard: exhaled biomarkers in lung disease 208
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study 208
Aging and airway inflammation 203
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome 197
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 197
Clinical and operational value of the extensively drug-resistant tuberculosis definition. 196
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use 196
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. 195
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment 194
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance. 191
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients. 186
Aging and induced-sputum cells. 186
A new Editorial Board of Monaldi Archives for Chest Disease 185
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. 182
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey 182
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics. 181
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae 181
History of tuberculosis and drug resistance 180
When kidneys and lungs suffer together 180
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. 178
Improving the TB case management: The International Standards for Tuberculosis Care. 178
Tuberculosis elimination: theory and practice in Europe 178
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects 178
Economic analysis of two structured treatment and teaching programs on asthma. 177
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate. 177
In vitro susceptibility testing and totally drug-resistant tuberculosis 177
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. 177
Ripped from the headlines: how can we harness communications to control TB? 176
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials 176
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study. 175
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 174
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance. 173
Brittle Asthma 172
Induced sputum to assess airway inflammation: a study of reproducibility. 171
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease 171
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 170
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD 170
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma 170
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. 169
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. 168
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 167
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. 166
Effects of intradermal injection of atrial natriuretic peptide. 166
Airway inflammation in patients affected by obstructive sleep apnea syndrome. 166
Markers of airway inflammation in pulmonary diseases assessed by induced sputum. 166
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 166
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation. 165
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD 165
Comparison of two methods of processing induced sputum: selected versus entire sputum. 164
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 164
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. 163
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. 163
Menopausal asthma: a new biological phenotype? 162
Airway inflammation in healthy smokers. 162
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit 162
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? 161
Recent developments in the diagnosis and management of tuberculosis 161
European union standards for tuberculosis care. 160
An electronic nose in the discrimination of patients with asthma and controls. 159
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. 159
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design 159
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. 158
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients 158
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial. 156
Effect of methacholine challenge on cellular composition of sputum induction. 155
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough 155
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. 155
Exhaled inflammatory markers in aspirin-induced asthma syndrome. 155
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact. 154
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment. 153
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy 153
Latex allergy and sensitization in cities: a survey in a population at risk 153
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy 152
Is bronchodilator the correct treatment for COPD subjects before EBUS? 152
Assembly 5: Airway diseases 152
Sputum induced cellularity in a group of traffic policemen. 151
SPUTUM AND EXHALED BREATH ANALYSIS 151
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. 150
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease 150
Management of drug resistantTB in patients with HIV co-infection 150
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: A non-inferiority, randomised, double-blind clinical trial 149
Tuberculosis elimination: Where are we now? 149
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. 148
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD 148
Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple? 148
Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018 147
The new frontiers of rehabilitation medicine in people with chronic disabling illnesses 147
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis 147
AIDS and tuberculosis control programmes: an integrated approach at educational level. 146
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease. 145
MDR-TB and XDR-TB: drug resistance and treatment outcomes. 144
Attenuation of induced bronchoconstriction in healthy subjects: effects of breathing depth. 144
Totale 17.634
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.557
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.011 0 0 0 0 0 413 196 373 635 283 418 693
2021/20222.742 315 328 168 70 83 185 204 176 157 486 221 349
2022/20233.395 441 147 291 360 225 701 39 366 452 148 121 104
2023/20246.222 840 865 1.323 1.037 1.175 404 101 117 185 94 51 30
2024/20254.451 53 93 781 151 180 355 163 271 523 447 319 1.115
2025/20263.810 539 566 685 1.167 703 150 0 0 0 0 0 0
Totale 36.063